spacer
spacer

PDBsum entry 3gzn

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Protein binding/ligase PDB id
3gzn

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
527 a.a. *
429 a.a. *
79 a.a. *
Ligands
B39 ×2
Metals
_ZN ×2
* Residue conservation analysis
PDB id:
3gzn
Name: Protein binding/ligase
Title: Structure of nedd8-activating enzyme in complex with nedd8 and mln4924
Structure: Nedd8-activating enzyme e1 regulatory subunit. Chain: a, c. Synonym: amyloid protein-binding protein 1, amyloid beta precursor protein-binding protein 1, 59 kda, app-bp1, proto-oncogene protein 1. Engineered: yes. Nedd8-activating enzyme e1 catalytic subunit. Chain: b, d. Synonym: ubiquitin-like modifier-activating enzyme 3, ubiquitin- activating enzyme 3, nedd8-activating enzyme e1c, ubiquitin-
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: appbp1, hpp1, nae1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Gene: uba3, ube1c. Gene: nedd8.
Resolution:
3.00Å     R-factor:   0.233     R-free:   0.287
Authors: M.D.Sintchak
Key ref: J.E.Brownell et al. (2010). Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell, 37, 102-111. PubMed id: 20129059
Date:
07-Apr-09     Release date:   02-Feb-10    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q13564  (ULA1_HUMAN) -  NEDD8-activating enzyme E1 regulatory subunit from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
534 a.a.
527 a.a.
Protein chains
Pfam   ArchSchema ?
Q8TBC4  (UBA3_HUMAN) -  NEDD8-activating enzyme E1 catalytic subunit from Homo sapiens
Seq:
Struc:
463 a.a.
429 a.a.
Protein chains
Pfam   ArchSchema ?
Q15843  (NEDD8_HUMAN) -  NEDD8 from Homo sapiens
Seq:
Struc:
81 a.a.
79 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains B, D: E.C.6.2.1.64  - E1 NEDD8-activating enzyme.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + [NEDD8 protein] + [E1 NEDD8-activating enzyme]-L-cysteine = AMP + diphosphate + [E1 NEDD8-activating enzyme]-S-[NEDD8 protein]-yl-L- cysteine
ATP
+ [NEDD8 protein]
+ [E1 NEDD8-activating enzyme]-L-cysteine
=
AMP
Bound ligand (Het Group name = B39)
matches with 42.11% similarity
+ diphosphate
+ [E1 NEDD8-activating enzyme]-S-[NEDD8 protein]-yl-L- cysteine
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Mol Cell 37:102-111 (2010)
PubMed id: 20129059  
 
 
Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ.
J.E.Brownell, M.D.Sintchak, J.M.Gavin, H.Liao, F.J.Bruzzese, N.J.Bump, T.A.Soucy, M.A.Milhollen, X.Yang, A.L.Burkhardt, J.Ma, H.K.Loke, T.Lingaraj, D.Wu, K.B.Hamman, J.J.Spelman, C.A.Cullis, S.P.Langston, S.Vyskocil, T.B.Sells, W.D.Mallender, I.Visiers, P.Li, C.F.Claiborne, M.Rolfe, J.B.Bolen, L.R.Dick.
 
  ABSTRACT  
 
The NEDD8-activating enzyme (NAE) initiates a protein homeostatic pathway essential for cancer cell growth and survival. MLN4924 is a selective inhibitor of NAE currently in clinical trials for the treatment of cancer. Here, we show that MLN4924 is a mechanism-based inhibitor of NAE and creates a covalent NEDD8-MLN4924 adduct catalyzed by the enzyme. The NEDD8-MLN4924 adduct resembles NEDD8 adenylate, the first intermediate in the NAE reaction cycle, but cannot be further utilized in subsequent intraenzyme reactions. The stability of the NEDD8-MLN4924 adduct within the NAE active site blocks enzyme activity, thereby accounting for the potent inhibition of the NEDD8 pathway by MLN4924. Importantly, we have determined that compounds resembling MLN4924 demonstrate the ability to form analogous adducts with other ubiquitin-like proteins (UBLs) catalyzed by their cognate-activating enzymes. These findings reveal insights into the mechanism of E1s and suggest a general strategy for selective inhibition of UBL conjugation pathways.
 

 

spacer

spacer